Hutyra-Gram Ötvös, R.; Krynska, H.; Gudoityte, G.; Skribek, M.; Oniscu, A.; Berkovska, O.; Strauß, K.; Zipprick, J.; Tamborero, D.; Alexeyenko, A.;
et al. Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response. Cancers 2025, 17, 2363.
https://doi.org/10.3390/cancers17142363
AMA Style
Hutyra-Gram Ötvös R, Krynska H, Gudoityte G, Skribek M, Oniscu A, Berkovska O, Strauß K, Zipprick J, Tamborero D, Alexeyenko A,
et al. Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response. Cancers. 2025; 17(14):2363.
https://doi.org/10.3390/cancers17142363
Chicago/Turabian Style
Hutyra-Gram Ötvös, Rita, Hanna Krynska, Greta Gudoityte, Marcus Skribek, Anca Oniscu, Olena Berkovska, Katharina Strauß, Jenny Zipprick, David Tamborero, Andrey Alexeyenko,
and et al. 2025. "Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response" Cancers 17, no. 14: 2363.
https://doi.org/10.3390/cancers17142363
APA Style
Hutyra-Gram Ötvös, R., Krynska, H., Gudoityte, G., Skribek, M., Oniscu, A., Berkovska, O., Strauß, K., Zipprick, J., Tamborero, D., Alexeyenko, A., Gad, A. K. B., Seashore-Ludlow, B., & Dobra, K.
(2025). Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response. Cancers, 17(14), 2363.
https://doi.org/10.3390/cancers17142363
